Evidence of vascular endothelial dysfunction in young patients with cystic fibrosis

Chest

Volumn 143, Issue 4, 2013, Pages 939-945

  Poore, Spencer ^a   Berry, Breana ^a   Eidson, Dabney ^a   McKie, Kathleen T ^a   Harris, Ryan A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ADOLESCENT; ADULT; AGE; ARTICLE; BICYCLE ERGOMETER; BIOAVAILABILITY; BLOOD VESSEL PARAMETERS; BODY MASS; BRACHIAL ARTERY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; EXERCISE; FEMALE; FLOW MEDIATED DILATION; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEIGHT; HUMAN; LUNG FUNCTION; MALE; NON INVASIVE PROCEDURE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SCHOOL CHILD; SPIROMETRY; VASCULAR ENDOTHELIUM; VASCULAR ENDOTHELIUM FUNCTION; VASODILATATION; VITAL CAPACITY; WORKLOAD;

EID: 84875977934     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1934     Document Type: Article

References (34)

1. Green D. Point: flow-mediated dilation does reflect nitric oxide-mediated endothelial function. J Appl Physiol. 2005; 99 (3): 1233 - 1234.
2. Uehata A, Lieberman EH, Gerhard MD, et al. Noninvasive assessment of endothelium-dependent flow-mediated dilation of the brachial artery. Vasc Med. 1997; 2 (2): 87 - 92.
3. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992; 340 (8828): 1111 - 1115.
4. Peinado VI, Barbera JA, Ramirez J, et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol. 1998; 274 (6 pt 1): L908 - L913.
5. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993; 88 (6): 2510 - 2516.
6. Maiorana A, O'Driscoll G, Taylor R, Green D. Exercise and the nitric oxide vasodilator system. Sports Med. 2003; 33 (14): 1013 - 1035.
7. Edwards DG, Schofield RS, Lennon SL, Pierce GL, Nichols WW, Braith RW. Effect of exercise training on endothelial function in men with coronary artery disease. Am J Cardiol. 2004; 93 (5): 617 - 620.
8. Guerci B, Kearney-Schwartz A, Böhme P, Zannad F, Drouin P. Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function. Diabetes Metab. 2001; 27 (4 pt 1): 425 - 434.
9. Wolff B, Lodziewski S, Bollmann T, Opitz CF, Ewert R. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost. Am Heart J. 2007 ; 153 (6): 1088.e1 - 1088.
10. Dinh Xuan AT, Higenbottam TW, Pepke-Zaba J, Clelland C, Wallwork J. Reduced endothelium-dependent relaxation of cystic fibrosis pulmonary arteries. Eur J Pharmacol. 1989; 163 (2-3): 401 - 403.
11. Henno P, Maurey C, Danel C, et al. Pulmonary vascular dysfunction in end-stage cystic fibrosis: role of NF-kappaB and endothelin-1. Eur Respir J. 2009; 34 (6): 1329 - 1337.
12. Romano M, Collura M, Lapichino L, et al. Endothelial perturbation in cystic fibrosis. Thromb Haemost. 2001; 86(6): 1363- 1367.
13. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995; 152 (3): 1107 - 1136.
14. Harris RA, Nishiyama SK, Wray DW, Richardson RS. Ultrasound assessment of flow-mediated dilation. Hypertension. 2010; 55 (5): 1075 - 1085.
15. Yeboah J, Folsom AR, Burke GL, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation. 2009; 120 (6): 502 - 509.
16. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 2007; 115 (18): 2390 - 2397.
17. Fraser KL, Tullis DE, Sasson Z, Hyland RH, Thornley KS, Hanly PJ. Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia. Chest. 1999; 115 (5): 1321 - 1328.
18. Perrin FM, Serino W. Ischaemic heart disease - a new issue in cystic fibrosis? J R Soc Med. 2010; 103 (suppl 1): S44 - S48.
19. Robert R, Thoreau V, Norez C, et al. Regulation of the cystic fibrosis transmembrane conductance regulator channel by beta-adrenergic agonists and vasoactive intestinal peptide in rat smooth muscle cells and its role in vasorelaxation. J Biol Chem. 2004; 279 (20): 21160 - 21168.
20. Michoud MC, Robert R, Hassan M, et al. Role of the cystic fibrosis transmembrane conductance channel in human airway smooth muscle. Am J Respir Cell Mol Biol. 2009; 40 (2): 217 - 222.
21. Tousson A, Van Tine BA, Naren AP, Shaw GM, Schwiebert LM. Characterization of CFTR expression and chloride channel activity in human endothelia. Am J Physiol. 1998; 275(6 Pt 1): C1555 - C1564.
22. McKone EF, Goss CH, Aitken ML. CFTR genotype as a predictor of prognosis in cystic fibrosis. Chest. 2006; 130 (5): 1441 - 1447.
23. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Collins CE, Garg ML. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr. 2001; 20 (suppl 2): 157 - 165.
24. Elizur A, Cannon CL, Ferkol TW. Airway inflammation in cystic fibrosis. Chest. 2008; 133 (2): 489 - 495.
25. Acevedo M, Arnáiz P, Barja S, et al. Relationship of C-reactive protein to adiposity, cardiovascular risk factors and subclinical atherosclerosis in healthy children [in Spanish]. Rev Esp Cardiol. 2007; 60 (10): 1051 - 1058.
26. Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation. 2004; 109 (16): 1955 - 1959.
27. Holmes MV, Jiang B, McNeill K, et al. Paradoxical association of C-reactive protein with endothelial function in rheumatoid arthritis. PLoS ONE. 2010; 5 (4): e10242.
28. Barr RG, Mesia-Vela S, Austin JH, et al. Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study. Am J Respir Crit Care Med. 2007; 176 (12): 1200 - 1207.
29. Eickhoff P, Valipour A, Kiss D, et al. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008; 178 (12): 1211 - 1218.
30. Moro L, Pedone C, Scarlata S, Malafarina V, Fimognari F, Antonelli-Incalzi R. Endothelial dysfunction in chronic obstructive pulmonary disease. Angiology. 2008; 59(3): 357- 364.
31. Orenstein DM, Franklin BA, Doershuk CF, et al. Exercise conditioning and cardiopulmonary fitness in cystic fibrosis. The effects of a three-month supervised running program. Chest. 1981; 80 (4): 392 - 398.
32. Salh W, Bilton D, Dodd M, Webb AK. Effect of exercise and physiotherapy in aiding sputum expectoration in adults with cystic fibrosis. Thorax. 1989; 44 (12): 1006 - 1008.
33. Schneiderman-Walker J, Pollock SL, Corey M, et al. A randomized controlled trial of a 3-year home exercise program in cystic fibrosis. J Pediatr. 2000; 136 (3): 304 - 310.
34. Huang B, Brennan KM, Budinger TF, Maltz JS. Assessment of endothelial function in the radial artery using inhaled albuterol. Conf Proc IEEE Eng Med Biol Soc 2007; 2007 : 3629 - 3631.